Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer

  • 0From the Center for Gastric Cancer (I.J.C., M.-C.K., Y.-I.K., S.-J.C., J.Y.L., C.G.K.) and the Biometrics Research Branch, Research Institute (B.P., B.-H.N.), National Cancer Center, Goyang, South Korea.

|

|

Summary

This summary is machine-generated.

Eradicating Helicobacter pylori in early gastric cancer patients significantly reduced the risk of developing new gastric cancers and improved gastric atrophy. This H. pylori treatment offers a promising strategy for preventing metachronous gastric cancer.

Area Of Science

  • Gastroenterology
  • Oncology
  • Infectious Disease

Background

  • Early gastric cancer patients often have extensive glandular atrophy, increasing their risk of metachronous gastric cancer.
  • The long-term impact of Helicobacter pylori eradication on histologic improvement and metachronous cancer prevention is not well-established.

Purpose Of The Study

  • To evaluate the long-term effects of Helicobacter pylori eradication therapy on preventing metachronous gastric cancer.
  • To assess the impact of H. pylori eradication on improving gastric glandular atrophy in patients with early gastric cancer.

Main Methods

  • A prospective, double-blind, placebo-controlled randomized trial involving 470 patients who underwent endoscopic resection for early gastric cancer or high-grade adenoma.
  • Patients received either H. pylori eradication therapy or a placebo, with primary outcomes including metachronous gastric cancer incidence and gastric atrophy grade improvement over 3-5.9 years.

Main Results

  • Metachronous gastric cancer developed in 7.2% of the H. pylori treatment group versus 13.4% in the placebo group (HR, 0.50; P=0.03).
  • Significant improvement in gastric corpus atrophy was observed in 48.4% of the treatment group compared to 15.0% in the placebo group (P<0.001).
  • Mild adverse events were more frequent in the treatment group, but no serious adverse events were reported.

Conclusions

  • H. pylori eradication therapy in early gastric cancer patients led to reduced rates of metachronous gastric cancer.
  • The treatment also demonstrated significant improvement in gastric corpus atrophy compared to placebo.
  • H. pylori eradication is a viable strategy for preventing metachronous gastric cancer and improving gastric histology.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy 01:16

1.4K

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...

Cancer Prevention 02:59

8.2K

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

Cancer Therapies 02:49

10.2K

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Targeted Cancer Therapies 02:57

9.0K

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Urinary Tract Calculi IV: Nutrition Therapy and Prevention 01:27

451

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...

Gastric Motility 01:16

3.3K

Gastric motility is the coordinated contraction and relaxation of stomach muscles that convert ingested food into chyme, a semi-liquid substance ready for further digestion in the intestines. The process begins with the vagus nerve inducing the relaxation of the smooth muscles in the fundus and body of the stomach, allowing these regions to expand and accommodate up to approximately 1.5 liters of food and liquid.
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...